Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2021-02-20 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Share Issue/Capital Change Classification · 95% confidence The document contains detailed tables listing investors, number of shares held pre- and post- a preferential issue, and the price per share for the equity consideration. The presence of multiple investors and share counts before and after the issue strongly indicates this is an announcement related to a share capital change, specifically a preferential share issue. There is no indication of financial statements, management discussion, or voting results. The document length is 3615 characters, which is relatively short but contains substantive data about shareholding changes due to a capital event. Therefore, this fits best under the category of Share Issue/Capital Change (SHA).
2021-02-20 English
In the Board Meeting of Wanbury Limited held today, i.e. on Saturday, 20th February, 2021, the following matters, among others, were discussed and approved by the BOD of the Company: ....
Regulatory Filings
2021-02-20 English
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/02/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI ....
Regulatory Filings
2021-02-17 English
Board Meeting — Fund Raising
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 166 characters, which is extremely short and does not contain any report content. It is likely an announcement or placeholder without actual report data. According to the MENU VS MEAL RULE, such a short document with no report content should be classified as a Regulatory Filing (RNS) as a fallback category.
2021-02-17 English
Financial Result Updates
Regulatory Filings
2021-02-12 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Wanbury Limited dated 12th February 2021, reporting the outcome of a Board Meeting where the standalone and consolidated unaudited financial results for the third quarter ended 31st December 2020 were approved. It includes the unaudited financial results, notes on accounting standards (Ind AS 34 for interim financial reporting), and a limited review report by the auditors. The document contains substantive financial data, including income, expenses, profit/loss, and notes on going concern and Covid-19 impact. The presence of unaudited quarterly financial results and a limited review report aligns with an Interim / Quarterly Report. It is not a full annual report (10-K), nor just an announcement of a report (RPA), and it is not a certification or attestation letter (RNS). Therefore, the document is best classified as an Interim / Quarterly Report (IR). Q3 2021
2021-02-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.